- Report
- December 2025
- 210 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- October 2025
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- November 2025
- 198 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- May 2025
- 226 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- February 2026
- 364 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 179 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 270 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 183 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- November 2025
- 183 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- April 2025
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- May 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more